NCT06979336 A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC) Status RECRUITING Phase PHASE2
NCT06975722 A Study to Investigate the Efficacy and Safety of SAR442970 in Adult Participants With Ulcerative Colitis Status RECRUITING Phase PHASE2
NCT06964113 A Study of Filgotinib 200 mg in Korean Participants With Moderately to Severely Active Ulcerative Colitis Under Routine Clinical Practice Status RECRUITING Phase PHASE4
NCT06937086 Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study Status RECRUITING Phase PHASE3
NCT06918093 A Comparative Evaluation of Different Histopathological Indices of Mucosal Healing in Ulcerative Colitis Status NOT_YET_RECRUITING Phase N/A
NCT06906445 A Study to Evaluate the Effect of Fecal Transplant and Dietary Changes on Disease Activity in Patients With Ulcerative Colitis on Advanced Therapies Status RECRUITING Phase NA
NCT06880744 A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab Status RECRUITING Phase PHASE3
NCT06865417 A Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis Status RECRUITING Phase PHASE3
NCT06856135 Expanded Access to Vedolizumab for Children and Teenagers With Ulcerative Colitis or Crohn's Disease in the USA Status AVAILABLE Phase N/A
NCT06838845 An Observational Study to Evaluate Effectiveness and Safety of Upadacitinib in Chinese Adult Participants With Moderate to Severely Active Ulcerative Colitis (UC) Status RECRUITING Phase N/A
NCT06788340 MOdel-Informed Precision Dosing of Ustekinumab and VEdolizumab in Inflammatory Bowel Disease Status NOT_YET_RECRUITING Phase PHASE4
NCT06784323 Tailored Anti-Inflammatory (A-I) Diet for Americans With Ulcerative Colitis (UC) Status RECRUITING Phase NA
NCT06780683 Efficacy and Safety of Upadacitinib in Inflammatory Bowel Disease Status RECRUITING Phase N/A
NCT06777706 Open Label Study to Assess Safety & Efficacy of QD for Induction of Remission in Pediatric Patients with UC Status COMPLETED Phase NA
NCT06764706 Study to Assess Change in Disease Activity of Risankizumab Treatment in Adult Participants With Moderate to Severe Ulcerative Colitis Status RECRUITING Phase N/A
NCT06764615 A Continuation Study of TAK-279 in Adults With Ulcerative Colitis (UC) and Crohn's Disease (CD) Status RECRUITING Phase PHASE2